Vivanza Biosciences Ltd
NSE: BSE: 530057
₹2.07
(-1.43%)
Wed, 22 Apr 2026, 04:55 pm
Market Cap84M
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KVivanza Biosciences Income Statement
| Particulars | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34.75M | 64.40M | 26.59M | 96.21M | 98.88M | 104.00M | 178.07M | 278.35M | 74.23M |
| Gross profit | — | — | -504.44K | — | 0 | 0 | 0 | -125.27K | 7.47M | 2.25M | 31.02K | 3.84M | 4.85M | 9.89M | 14.21M | 136.00K |
| Operating expenses (excl. COGS) | -10.00K | -10.00K | -2.35M | -10.55M | -509.35K | -525.36K | -607.76K | -2.90M | -1.45M | -2.45M | -3.37M | -2.86M | -4.22M | -2.97M | -3.61M | -3.77M |
| Selling/general/admin expenses, total | -10.00K | -10.00K | -1.36M | -10.55M | -509.35K | -525.36K | -607.76K | -2.57M | -1.45M | -2.44M | -2.73M | -2.54M | -4.02M | -2.60M | -3.24M | -3.41M |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Selling/general/admin expenses, other | -10.00K | -10.00K | -1.36M | -10.55M | -509.35K | -525.36K | -607.76K | -2.57M | -1.45M | -2.44M | -2.73M | -2.54M | -4.02M | -2.60M | -3.24M | -3.41M |
| Other operating expenses, total | 0 | 0 | -988.51K | 0 | 0 | 0 | 0 | -328.81K | -2.76K | -12.75K | -635.62K | -314.87K | -204.00K | -368.00K | -368.00K | -368.00K |
| Operating income | -10.00K | -10.00K | -2.86M | -10.55M | -509.35K | -525.36K | -607.76K | -3.03M | 6.02M | -198.55K | -3.34M | 983.90K | 629.00K | 6.92M | 10.60M | -3.64M |
| Non-operating income, total | 0 | 0 | 842.33K | -5.44M | -25.34K | -547 | 4.44K | -88.17K | -3.69M | -4.21M | 1.28M | 250.96K | 2.70M | 243.00K | -3.65M | -3.02M |
| Interest expense, net of interest capitalized | — | — | -4.89M | -4.09K | -336 | -547 | -563 | -434.37K | -3.70M | -4.21M | -4.42M | -4.74M | -4.32M | -4.25M | -4.19M | -3.54M |
| Interest capitalized | — | 0 | — | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 0 | 0 | 5.73M | -4.75M | 0 | 0 | 5.00K | 130.78K | 10.57K | 0 | 5.70M | 4.99M | 7.02M | 4.50M | 541.00K | 524.00K |
| Non-operating interest income | — | — | — | — | — | — | — | — | — | 0 | 0 | 4.23M | 0 | 0 | 0 | 0 |
| Miscellaneous non-operating expense | 0 | 0 | 5.73M | -4.75M | 0 | 0 | 5.00K | 130.78K | 10.57K | 0 | 5.70M | 762.24K | 7.02M | 4.50M | 541.00K | 524.00K |
| Unusual income/expense | — | — | — | -685.19K | -25.00K | — | — | 215.43K | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax income | -10.00K | -10.00K | -2.02M | -15.99M | -534.68K | -525.91K | -603.32K | -3.11M | 2.34M | -4.41M | -2.06M | 1.23M | 3.33M | 7.17M | 6.95M | -6.66M |
| Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -281.48K | 0 | 0 | -481.51K | -4.00K | -1.18M | -1.48M | -84.00K |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | — | 0 | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -10.00K | -10.00K | -2.02M | -15.99M | -534.68K | -525.91K | -603.32K | -3.11M | 2.05M | -4.41M | -2.06M | 753.35K | 3.33M | 5.98M | 5.47M | -6.74M |
| Net income | -10.00K | -10.00K | -2.02M | -15.99M | -534.68K | -525.91K | -603.32K | -3.11M | 2.05M | -4.41M | -2.06M | 753.35K | 3.33M | 5.98M | 5.47M | -6.74M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -10.00K | -10.00K | -2.02M | -15.99M | -534.68K | -525.91K | -603.32K | -3.11M | 2.05M | -4.41M | -2.06M | 753.35K | 3.33M | 5.98M | 5.47M | -6.74M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | -10.00K | -10.00K | -2.86M | -10.55M | -509.35K | -525.36K | -607.76K | -3.03M | 6.02M | -198.55K | -3.34M | 1.08M | 703.00K | 6.95M | 10.72M | -3.50M |
| EBIT | -10.00K | -10.00K | -2.86M | -10.55M | -509.35K | -525.36K | -607.76K | -3.03M | 6.02M | -198.55K | -3.34M | 983.90K | 629.00K | 6.92M | 10.60M | -3.64M |
| Total operating expenses | -10.00K | -10.00K | -2.86M | -10.55M | -509.35K | -525.36K | -607.76K | -37.77M | -58.38M | -26.79M | -99.55M | -97.90M | -103.37M | -171.15M | -267.75M | -77.87M |
| Prepaid expenses | — | — | — | 0 | 423.47K | 423.47K | — | — | — | — | — | — | — | — | — | — |
| Deferred income, current | — | — | — | — | — | — | — | — | — | 4.77M | 5.43M | 4.31M | 3.98M | 6.60M | 4.19M | 5.42M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | 0 | — | — | 0 | 0 | — | — | — | — | — | — | — | — | — | — |
| Deferred income, non-current | — | — | — | — | — | — | — | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | 0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800